Join the Child Neurology Society on Wednesday, June 10, 2026, for an insightful webinar on the complexities of managing Duchenne muscular dystrophy (DMD).
Led by Daniel Guillen Mendoza, this session will take a closer look at the underlying biology and progression of DMD, address unmet needs in current care, and explore evolving therapeutic approaches aimed at improving outcomes for patients.
This industry-sponsored webinar is made possible by the support of ITF Therapeutics, a valued CNS annual partner. Their sponsorship enables us to bring you cutting-edge insights and discussions from industry experts.
Speaker
Daniel Guillen Mendoza, MD